Kazuhiro Niizato Selected Research

DNA (Deoxyribonucleic Acid)

1/2020	Epigenome-wide association study of narcolepsy-affected lateral hypothalamic brains, and overlapping DNA methylation profiles between narcolepsy and multiple sclerosis.
1/2015	Assessment of copy number variations in the brain genome of schizophrenia patients.
3/2006	A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiro Niizato Research Topics

Disease

17	Schizophrenia (Dementia Praecox) 01/2021 - 11/2002
6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 04/2010
4	Atrophy 01/2021 - 07/2005
3	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 12/2013
2	Cognitive Dysfunction 01/2022 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2020 - 04/2010
2	TDP-43 Proteinopathies 10/2020 - 04/2010
2	Frontotemporal Dementia (Semantic Dementia) 10/2020 - 04/2010
1	Dementia (Dementias) 01/2022
1	Sleep Wake Disorders 01/2020
1	Cataplexy 01/2020
1	Narcolepsy 01/2020
1	Chronic Traumatic Encephalopathy 12/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2019
1	Tardive Dyskinesia 04/2010
1	Progressive Multifocal Leukoencephalopathy 12/2009
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 02/2008
1	Parkinson Disease (Parkinson's Disease) 09/2006
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2006
1	Alzheimer Disease (Alzheimer's Disease) 06/2006
1	Apraxias (Dyspraxia) 07/2005
1	Agnosia (Visual Agnosia) 07/2005
1	Diffuse Neurofibrillary Tangles with Calcification 07/2005

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
5	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2021 - 04/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2006
2	UbiquitinIBA 12/2013 - 04/2010
2	Glutamic Acid (Glutamate)FDA Link 01/2012 - 04/2008
1	Pharmaceutical PreparationsIBA 01/2021
1	Glucuronic Acid (Glucuronate)IBA 01/2021
1	Advanced Glycation End ProductsIBA 01/2021
1	Ataxin-2IBA 10/2020
1	OrexinsIBA 01/2020
1	tau Proteins (tau Protein)IBA 12/2019
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 12/2018
1	Myelin-Oligodendrocyte GlycoproteinIBA 08/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2012
1	Vitamin B 6IBA 06/2010
1	Biological ProductsIBA 06/2010
1	pentosidineIBA 06/2010
1	Biomarkers (Surrogate Marker)IBA 06/2010
1	PyridoxalIBA 06/2010
1	CB2 Cannabinoid ReceptorIBA 05/2010
1	CannabinoidsIBA 05/2010
1	EndocannabinoidsIBA 05/2010
1	P-2 (P 2)IBA 04/2010
1	perlecanIBA 04/2010
1	Antipsychotic Agents (Antipsychotics)IBA 04/2010
1	Dopamine AntagonistsIBA 04/2010
1	LuciferasesIBA 04/2008
1	metabotropic glutamate receptor 7IBA 04/2008
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2008
1	Phenytoin (Dilantin)FDA LinkGeneric 02/2008
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 12/2006
1	G-Protein-Coupled Receptor Kinase 5IBA 09/2006
1	Amyloid beta-PeptidesIBA 06/2006
1	4- N,N- dimethylamino- 1- naphthylisothiocyanateIBA 07/2005
1	Neuropeptide YIBA 03/2004
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2003

Therapy/Procedure

1	Treatment Delay 01/2022
1	Psychosurgery (Lobotomy) 12/2019
1	Therapeutics 04/2010